Advertisement

Conference Coverage

ACC 2017

See All Content See past conferences

Washington, DC

March 17, 2017

March 19, 2017

Editor's Corner

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

My prediction? The biggest impact of ACC 2017 won’t come from a trial, a drug, or a device, but from the faces we saw in the Main Tent.

News

News • Interventional

DECISION-CTO: PCI Stumbles for Stable CAD Patients With Chronic Total Occlusions

Yael L. Maxwell

March 19, 2017

News • Interventional

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

March 18, 2017

News • Interventional

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

Michael O'Riordan

March 18, 2017

News • Interventional

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

March 27, 2017

News • Interventional

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

March 24, 2017

Slides

First Results from the SURTAVI Clinical Trial

Presenter: Michael J. Reardon

March 17, 2017

DECISION-CTO: Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion

Presenter: Seung-Jung Park

March 20, 2017

iFR vs FFR-guided Coronary Intervention – iFR-SWEDEHEART

Presenter: Matthias Götberg

March 20, 2017

The RAD-MATRIX Study

Presenter: Alessandro Sciahbasi

March 19, 2017

Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis

Presenter: Stephen J Nicholls

March 20, 2017

Live Blog

Editor's Corner

Live From Washington: ACC 2017, Day One

March 17, 2017

Editor's Corner

Live From Washington: ACC 2017, Day Two

March 18, 2017

Editor's Corner

Live From Washington: ACC 2017, Day Three

March 19, 2017

Advertisement

All Conference Content

Country